Cipher Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CIPHER
CIPHER has three approved drugs.
There is one US patent protecting CIPHER drugs.
Drugs and US Patents for Cipher
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cipher Pharms Inc | CONZIP | tramadol hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 022370-001 | May 7, 2010 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| Cipher Pharms Inc | CONZIP | tramadol hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 022370-004 | Aug 1, 2011 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Cipher Pharms Inc | CONZIP | tramadol hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 022370-003 | May 7, 2010 | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Cipher Pharms Inc | LIPOFEN | fenofibrate | CAPSULE;ORAL | 021612-002 | Jan 11, 2006 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Cipher Pharms Inc | LIPOFEN | fenofibrate | CAPSULE;ORAL | 021612-001 | Jan 11, 2006 | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Cipher Pharms Inc | CONZIP | tramadol hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 022370-002 | May 7, 2010 | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Cipher | NATROBA | spinosad | SUSPENSION;TOPICAL | 022408-001 | Jan 18, 2011 | RX | Yes | Yes | 9,895,388 | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Cipher
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Cipher Pharms Inc | CONZIP | tramadol hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 022370-002 | May 7, 2010 | 7,858,118 | ⤷ Start Trial |
| Cipher | NATROBA | spinosad | SUSPENSION;TOPICAL | 022408-001 | Jan 18, 2011 | 5,496,931 | ⤷ Start Trial |
| Cipher | NATROBA | spinosad | SUSPENSION;TOPICAL | 022408-001 | Jan 18, 2011 | 6,342,482 | ⤷ Start Trial |
| Cipher Pharms Inc | CONZIP | tramadol hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 022370-001 | May 7, 2010 | 7,858,118 | ⤷ Start Trial |
| Cipher Pharms Inc | LIPOFEN | fenofibrate | CAPSULE;ORAL | 021612-003 | Jan 11, 2006 | 5,545,628 | ⤷ Start Trial |
| Cipher | NATROBA | spinosad | SUSPENSION;TOPICAL | 022408-001 | Jan 18, 2011 | 7,030,095 | ⤷ Start Trial |
| Cipher Pharms Inc | CONZIP | tramadol hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 022370-003 | May 7, 2010 | 7,858,118 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

